Edit |   |
---|---|
Antigenic Specificity | LOXL2, Human (Simtuzumab biosimilar) |
Clone | Simtuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM, IP, ELISA, Neut, FuncS |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human LOXL2 Recombinant Antibody. Simtuzumab (INN, formerly GS 6624) is a humanized monoclonal antibody designed for the treatment of fibrosis. It binds to LOXL2 and acts as an immunomodulator. In January 2016, Gilead Sciences terminated its Phase 2 clinical study in patients with idiopathic pulmonary fibrosis (IPF) due to lack of efficacy. |
Immunogen | n/a |
Other Names | Anti-LOXL2 Recombinant Antibody, Research Grade Simtuzumab, Anti-Human LOXL2 Recombinant Antibody, AB0024, GS-6624, Antibody Drug Analogues, Monoclonal Antibody, YR1290, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1318075-13-6 |
Catalog # | YR1290 |
Price | please inquire |
Order / More Info | LOXL2, Human (Simtuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |